DUBLIN--(BUSINESS WIRE)--The "2018 and Beyond: Japan Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025" report has been added to ResearchAndMarkets.com's offering.
Spending on medicines and healthcare in Japan witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/expansion opportunities. Both Pharmaceutical sales and consumption are on the rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Japan and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Japan healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Japan healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Key Players Profiled
- Johnson and Johnson
- Bayer
- Novartis
- Pfizer
- Roche
- Sanofi
- Merck
- Gilead Sciences
- GlaxoSmithKline
- AstraZeneca
Key Topics Covered
1 List of Tables & Figures
2 Executive Summary
3 Japan Pharmaceutical Market Strategic Analysis Review
4 Japan Pharmaceutical Market Outlook
5 Japan Healthcare Market Outlook
6 Japan Healthcare Market Statistics
7 Japan Clinical Trials Research Industry
8 Japan Demographic and Macro-Economic Profile
9 Business Profiles of Leading Pharmaceutical Companies
10 Recent Industry Developments in Japan Pharmaceuticals and Healthcare Markets
11 Appendix
For more information about this report visit https://www.researchandmarkets.com/research/h4pbvx/japan?w=4
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.